D-0168-2021 Class I Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-0168-2021 was initiated by AVKARE Inc. on Dec 7, 2020 and is designated Class I. Reason for recall: Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility. The recall status is terminated (terminated Oct 16, 2023). Affected quantity: 14368 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 23, 2020
Initiation Date
Dec 7, 2020
Termination Date
Oct 16, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14368 bottles

Product description

TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-834-10

Reason for recall

Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

Distribution pattern

Nationwide within the U.S.

Code information

Lot: 36783 Exp. 06/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0168-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0168-2021. Report a data issue: hello@regdatalab.com.